Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement for Older Men With Sarcopenia
NCT00240981Phase 4Terminated
- Sponsor
- Boston Medical Center
- Start
- Jan 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Testosterone TEPI patch in Sarcopenia and Hypogonadism (2 arms), sponsored by Boston Medical Center. Primary endpoint: Changes in Physical Performance Measured by an Exercise Testing Regimen at 6 months. Started Jan 2005; status: terminated.
02
Drugs
Testosterone TEPI patch
03
Conditions
SarcopeniaHypogonadism
Beyond the preview
Go deeper on NCT00240981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240981.